Structural, morphological, and functional diversity of amyloid oligomers
The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
Protein misfolding and aggregation are known to play a crucial role in a number of important human diseases (Alzheimer's, Parkinson's, prion, diabetes, cataracts, etc.) as well as in a multitude of physiological processes. Protein aggregation is a highly complex process resulting in a variety of aggregates with different structures and morphologies. Oligomeric protein aggregates (amyloid oligomers) are formed as both intermediates and final products of the aggregation process. They are believed to play an important role in many protein aggregation‐related diseases, and many of them are highly cytotoxic. Due to their instability and structural heterogeneity, information about structure, mechanism of formation, and physiological effects of amyloid oligomers is sparse. This review attempts to summarize the existing information on the major properties of amyloid oligomers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Cognitive effects of cell-derived and synthetically derived Aβ oligomers
Reed, M. N., Hofmeister, J. J., Jungbauer, L., Welzel, A. T., Yu, C., Sherman, M. A., Lesné, S., LaDu, M. J., Walsh, D. M., Ashe, K. H., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.007 · Cited by 131
RetractedProtein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Conformation-specific antibodies can distinguish between different conformations of amyloid oligomers [158,159,166,170,171].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434 · cited 10×
“A variety of aromatic molecules such as EGCG [31,50,51], baicalein [52], dopamine [53–55], other polyphenols [56], thioflavins [57], curcumin [58–60], an anti-PD drug selengiline [61], b-hairpins [62] and many other compounds [63,64] induced formation of mostly disordered a-synuclein oligomers, although in some cases…”
BackgroundInfluentialAmyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules
Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P. R., Simon, R., Schubert, D., et al. (2009) · Science · doi:10.1126/science.1173155 · Cited by 1,048
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
Trans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 1,002
Bernstein, S. L., Dupuis, N. F., Lazo, N. D., Wyttenbach, T., Condron, M. M., Bitan, G., Teplow, D. B., Shea, J.-E., Ruotolo, B. T., Robinson, C. V., et al. (2009) · Nature Chemistry · doi:10.1038/nchem.247 · Cited by 918
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805 · cited 1×
“In addition, Ab [29,30] and a-synuclein [115,116] oligomers can assemble into annular protofibrils, doughnut-shaped structures”
BackgroundStructural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 2×
“Conformation-specific antibodies can distinguish between different conformations of amyloid oligomers [158,159,166,170,171].”
BackgroundMethodKayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773 · cited 2×
“Conformation-specific antibodies can distinguish between different conformations of amyloid oligomers [158,159,166,170,171].”
Self-citationStructure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 770 · cited 2×
“For example, for small Ab [26] and tau [134] oligomers, cytotoxicity increased with oligomer size.”
BackgroundA First Line of Stress Defense: Small Heat Shock Proteins and Their Function in Protein Homeostasis
Haslbeck, M., & Vierling, E. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.002 · Cited by 606 · cited 2×
“morphologies, with the size and structure of the oligomers dictated by the features of the N- and C-termini [177,178,180].”
BackgroundCommon mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569
Fauvet, B., Mbefo, M. K., Fares, M.-B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318949 · Cited by 566
A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties
Si, K., Lindquist, S., & Kandel, E. R. (2003) · Cell · doi:10.1016/s0092-8674(03)01020-1 · Cited by 563
Atomic View of a Toxic Amyloid Small Oligomer
Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., et al. (2012) · Science · doi:10.1126/science.1213151 · Cited by 563 · cited 4×
“strands in the PrP peptide hexamer [91] and the absence of these strands in the aB crystalline fragment hexamer [15].”
BackgroundInfluentialA causative link between the structure of aberrant protein oligomers and their toxicity
Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.283 · Cited by 552 · cited 2×
“well-packed hydrophobic core that resulted in solvent exposure of the most hydrophobic regions of the protein sequence [135].”
BackgroundWu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., Steinberg, J. I., Margittai, M., Kayed, R., Zurzolo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394528 · Cited by 537 · cited 1×
“rils [28], and oligomer seeding has been shown for tau [121,123], a-synuclein [49,124], and ataxin [125].”
BackgroundIdentification of oligomers at early stages of tau aggregation in Alzheimer's disease
Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527 · cited 1×
“Conformation-specific antibodies can distinguish between different conformations of amyloid oligomers [158,159,166,170,171].”
BackgroundSelf-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Guerrero-Munoz, M. J., Kiritoshi, T., Neugebauer, V., Jackson, G. R., & Kayed, R. (2012) · Scientific Reports · doi:10.1038/srep00700 · Cited by 502 · cited 2×
“pletely sequence-specific, as cross-seeding was observed between oligomers of Ab and tau [123], Ab40 and Ab42 [126], TDP-43 and Ab [127], and human and rat IAPP [128].”
BackgroundAntiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide
Cerf, E., Sarroukh, R., Tamamizu-Kato, S., Breydo, L., Derclaye, S., Dufrêne, Y. F., Narayanaswami, V., Goormaghtigh, E., Ruysschaert, J.-M., & Raussens, V. (2009) · Biochemical Journal · doi:10.1042/bj20090379 · Cited by 494
Self-citationXue, W.-F., Homans, S. W., & Radford, S. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711664105 · Cited by 476
Chen, S. W., Drakulic, S., Deas, E., Ouberai, M., Aprile, F. A., Arranz, R., Ness, S., Roodveldt, C., Guilliams, T., De-Genst, E. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421204112 · Cited by 460 · cited 2×
“Force spectroscopy [40] and other methods [39] showed that a-synuclein oligomer stabil-”
BackgroundMethodPathway Complexity of Prion Protein Assembly into Amyloid
Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B., & Cohen, F. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111402200 · Cited by 438 · cited 3×
“were b-sheet rich and had lower stability and lower extent of b-structure compared to fibrils [90,92,93].”
BackgroundSi, K., Choi, Y.-B., White-Grindley, E., Majumdar, A., & Kandel, E. R. (2010) · Cell · doi:10.1016/j.cell.2010.01.008 · Cited by 393
Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization
Poirier, M. A., Li, H., Macosko, J., Cai, S., Amzel, M., & Ross, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205809200 · Cited by 367 · cited 1×
“can also assemble into linear protofibrils with beads-on-a-string morphology [117,118].”
BackgroundBleiholder, C., Dupuis, N. F., Wyttenbach, T., & Bowers, M. T. (2011) · Nature Chemistry · doi:10.1038/nchem.945 · Cited by 366 · cited 2×
“25], and other peptides [99] were shown to be primarily unstructured.”
BackgroundSmall Molecule Inhibitors of α-Synuclein Filament Assembly
Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., Hisanaga, S.-I., Goedert, M., & Hasegawa, M. (2006) · Biochemistry · doi:10.1021/bi0600749 · Cited by 365
Role of Water in Protein Aggregation and Amyloid Polymorphism
Thirumalai, D., Reddy, G., & Straub, J. E. (2012) · Accounts of Chemical Research · doi:10.1021/ar2000869 · Cited by 362 · cited 1×
“ceeds, oligomer size and b-sheet content increase [104,106].”
BackgroundProtein oligomerization: How and why
Ali, M. H., & Imperiali, B. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.037 · Cited by 356 · cited 1×
“by the majority of cellular proteins [174]? While there is significant structural variability among both types of oligomers, func-”
BackgroundStructural Characterization of a Soluble Amyloid β-Peptide Oligomer
Yu, L., Edalji, R., Harlan, J. E., Holzman, T. F., Lopez, A. P., Labkovsky, B., Hillen, H., Barghorn, S., Ebert, U., Richardson, P. L., et al. (2009) · Biochemistry · doi:10.1021/bi802046n · Cited by 354 · cited 6×
“A – globulomer, Ab42 [33]; B – hexamer, b2-microglobulin [85]; C – hexamer, PrP fragment [91]A; D – hexamer, aB-crystallin fragment [15].”
BackgroundInfluentialAnnular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer
Kayed, R., Pensalfini, A., Margol, L., Sokolov, Y., Sarsoza, F., Head, E., Hall, J., & Glabe, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808591200 · Cited by 348 · cited 2×
“In the presence of lipid bilayers, these oligomers could be converted to annular protofibrils also shown to be b-sheet rich [29,30].”
BackgroundCompeting Pathways Determine Fibril Morphology in the Self-assembly of β2-Microglobulin into Amyloid
Gosal, W. S., Morten, I. J., Hewitt, E. W., Smith, D. A., Thomson, N. H., & Radford, S. E. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.040 · Cited by 343 · cited 1×
“At this point no solid proof of existence of on-pathway oligomers has been provided while a variety of oligomers formed by different proteins and peptides have been shown to be off-pathway [28,31,90,104,131,132].”
BackgroundType 2 diabetes as a protein misfolding disease
Mukherjee, A., Morales-Scheihing, D., Butler, P. C., & Soto, C. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.04.005 · Cited by 342
Ostwald Ripening: A Synthetic Approach for Hollow Nanomaterials
Chun Zeng, H. (2007) · Current Nanoscience · doi:10.2174/157341307780619279 · Cited by 341
Monoclonal antibodies that target pathological assemblies of Aβ
Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04157.x · Cited by 314 · cited 1×
“NU1 and NU4) also recognize amyloid fibrils [148].”
BackgroundToxic fibrillar oligomers of amyloid-β have cross-β structure
Stroud, J. C., Liu, C., Teng, P. K., & Eisenberg, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203193109 · Cited by 303
Secondary Structure of α-Synuclein Oligomers: Characterization by Raman and Atomic Force Microscopy
Apetri, M. M., Maiti, N. C., Zagorski, M. G., Carey, P. R., & Anderson, V. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.071 · Cited by 283
The Persistence of Long-Term Memory
Bailey, C. H., Kandel, E. R., & Si, K. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.017 · Cited by 277
Levin, A., Mason, T. O., Adler-Abramovich, L., Buell, A. K., Meisl, G., Galvagnion, C., Bram, Y., Stratford, S. A., Dobson, C. M., Knowles, T. P. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6219 · Cited by 275
Bemporad, F., & Chiti, F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.003 · Cited by 275 · cited 4×
“ceeds, oligomer size and b-sheet content increase [104,106].”
BackgroundInfluentialOne size does not fit all: The oligomeric states of αB crystallin
Delbecq, S. P., & Klevit, R. E. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.021 · Cited by 263
Curcumin inhibits aggregation of α-synuclein
Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., & Galvin, J. E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0332-4 · Cited by 263
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
O'Nuallain, B., Freir, D. B., Nicoll, A. J., Risse, E., Ferguson, N., Herron, C. E., Collinge, J., & Walsh, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3537-10.2010 · Cited by 259 · cited 1×
“For example, Ab dimers previously believed to be cytotoxic were shown to be inert but capable of converting to larger cytotoxic oligomers [11].”
BackgroundCappai, R., Leck, S., Tew, D. J., Williamson, N. A., Smith, D. P., Galatis, D., Sharpies, R. A., Curtain, C. C., Ali, F. E., Cherny, R. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3437fje · Cited by 257
Bodner, R. A., Outeiro, T. F., Altmann, S., Maxwell, M. M., Cho, S. H., Hyman, B. T., McLean, P. J., Young, A. B., Housman, D. E., & Kazantsev, A. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511256103 · Cited by 256 · cited 1×
“selengiline [61], b-hairpins [62] and many other compounds [63,64] induced formation of mostly disordered a-synuclein oligomers, although in some cases [52] the residual b-structure was found.”
BackgroundThe Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Lorenzen, N., Nielsen, S. B., Buell, A. K., Kaspersen, J. D., Arosio, P., Vad, B. S., Paslawski, W., Christiansen, G., Valnickova-Hansen, Z., Andreasen, M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411577t · Cited by 255 · cited 2×
“to be antiparallel judging from FTIR spectra [17,38,43].”
BackgroundStructural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease
Pauwels, K., Williams, T. L., Morris, K. L., Jonckheere, W., Vandersteen, A., Kelly, G., Schymkowitz, J., Rousseau, F., Pastore, A., Serpell, L. C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264473 · Cited by 253
A Helical Structural Nucleus Is the Primary Elongating Unit of Insulin Amyloid Fibrils
Vestergaard, B., Groenning, M., Roessle, M., Kastrup, J. S., de Weert, M. V., Flink, J. M., Frokjaer, S., Gajhede, M., & Svergun, D. I. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050134 · Cited by 253 · cited 1×
“folded proteins such as insulin [100,101], SOD-1 [102], and acylphosphatase [103,104] largely preserved the native fold of”
BackgroundLee, E. B., Leng, L. Z., Zhang, B., Kwong, L., Trojanowski, J. Q., Abel, T., & Lee, V. M.-Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511018200 · Cited by 252
Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure
Celej, M. S., Sarroukh, R., Goormaghtigh, E., Fidelio, G. D., Ruysschaert, J.-M., & Raussens, V. (2012) · Biochemical Journal · doi:10.1042/bj20111924 · Cited by 245
Toxic species in amyloid disorders: Oligomers or mature fibrils
Taneja, V., Verma, M., & Vats, A. (2015) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.144284 · Cited by 239
Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition
Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., & Jucker, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-11.2011 · Cited by 237
Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., & Rydel, R. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2381-04.2005 · Cited by 233 · cited 1×
“It has also been proposed that the process of membrane-mediated aggregation of Ab is sufficient to cause cytotoxicity [144,145], possibly due to the formation of transient, highly toxic oligomers.”
BackgroundEvidence for Proteotoxicity in β Cells in Type 2 Diabetes
Gurlo, T., Ryazantsev, S., Huang, C.-J., Yeh, M. W., Reber, H. A., Hines, O. J., O'Brien, T. D., Glabe, C. G., & Butler, P. C. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090532 · Cited by 228
Mechanisms of Protein Seeding in Neurodegenerative Diseases
Walker, L. C., Diamond, M. I., Duff, K. E., & Hyman, B. T. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1453 · Cited by 226 · cited 1×
“In fact, there is some evidence that, in addition to that of fibrils, self-propagation of Ab [119,120] and”
BackgroundMethionine oxidation inhibits fibrillation of human α‐synuclein in vitro
Uversky, V. N., Yamin, G., Souillac, P. O., Goers, J., Glaser, C. B., & Fink, A. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02638-8 · Cited by 222
Self-citationFang, Y.-S., Tsai, K.-J., Chang, Y.-J., Kao, P., Woods, R., Kuo, P.-H., Wu, C.-C., Liao, J.-Y., Chou, S.-C., Lin, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5824 · Cited by 211 · cited 1×
“pletely sequence-specific, as cross-seeding was observed between oligomers of Ab and tau [123], Ab40 and Ab42 [126], TDP-43 and Ab [127], and human and rat IAPP [128].”
BackgroundGhosh, D., Singh, P. K., Sahay, S., Jha, N. N., Jacob, R. S., Sen, S., Kumar, A., Riek, R., & Maji, S. K. (2015) · Scientific Reports · doi:10.1038/srep09228 · Cited by 211 · cited 3×
“a-synuclein), a-helical intermediates may also be involved [80,81,107].”
BackgroundMannini, B., Mulvihill, E., Sgromo, C., Cascella, R., Khodarahmi, R., Ramazzotti, M., Dobson, C. M., Cecchi, C., & Chiti, F. (2014) · ACS Chemical Biology · doi:10.1021/cb500505m · Cited by 204 · cited 1×
“Progressive accumulation of structural information about amyloid oligomers allowed researchers to reveal some of the structural features of these aggregates that account for their cytotoxicity: small size and high surface hydrophobicity [133].”
BackgroundHow Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro
Lorenzen, N., Nielsen, S. B., Yoshimura, Y., Vad, B. S., Andersen, C. B., Betzer, C., Kaspersen, J. D., Christiansen, G., Pedersen, J. S., Jensen, P. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554667 · Cited by 202 · cited 9×
“A variety of aromatic molecules such as EGCG [31,50,51], baicalein [52], dopamine [53–55], other polyphenols [56], thioflavins [57], curcumin [58–60], an anti-PD drug selengiline [61], b-hairpins [62] and many other compounds [63,64] induced formation of mostly disordered a-synuclein oligomers, although in some cases…”
BackgroundInfluentialCurcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Wang, M. S., Boddapati, S., Emadi, S., & Sierks, M. R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-57 · Cited by 197
Structural Properties of Pore-Forming Oligomers of α-Synuclein
Kim, H.-Y., Cho, M.-K., Kumar, A., Maier, E., Siebenhaar, C., Becker, S., Fernandez, C. O., Lashuel, H. A., Benz, R., Lange, A., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9077599 · Cited by 196
Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation
Qin, Z., Hu, D., Han, S., Reaney, S. H., Di Monte, D. A., & Fink, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608126200 · Cited by 191
Ladiwala, A. R. A., Dordick, J. S., & Tessier, P. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173856 · Cited by 188 · cited 1×
“Partially disordered Ab oligomers formed in the presence of polyphenols were non-toxic [31,136,137], whereas more struc-”
BackgroundOut-of-register β-sheets suggest a pathway to toxic amyloid aggregates
Liu, C., Zhao, M., Jiang, L., Cheng, P.-N., Park, J., Sawaya, M. R., Pensalfini, A., Gou, D., Berk, A. J., Glabe, C. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218792109 · Cited by 186 · cited 2×
“It has been proposed that these antibodies recognized the out of register b sheets [15,163].”
BackgroundDirect characterization of amyloidogenic oligomers by single-molecule fluorescence
Orte, A., Birkett, N. R., Clarke, R. W., Devlin, G. L., Dobson, C. M., & Klenerman, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803086105 · Cited by 184 · cited 1×
“tides, the conversion of amyloid oligomers from native-like to b-sheet rich forms has been shown to involve internal reorganization rather than dissociation and reassembly [99,112,113].”
BackgroundPathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
Sengupta, U., Guerrero-Muñoz, M. J., Castillo-Carranza, D. L., Lasagna-Reeves, C. A., Gerson, J. E., Paulucci-Holthauzen, A. A., Krishnamurthy, S., Farhed, M., Jackson, G. R., & Kayed, R. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.019 · Cited by 181 · cited 1×
“Furthermore, hybrid oligomers of a-synuclein and tau [129] as well as Ab and other”
BackgroundEffects of nitration on the structure and aggregation of α-synuclein
Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S., Lyubchenko, Y. L., & Fink, A. L. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.014 · Cited by 181
Self-citationStructural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.039 · Cited by 177 · cited 2×
“EGCG [31,50,51], baicalein [52], dopamine [53–55], other polyphenols [56], thioflavins [57], curcumin [58–60], an anti-PD drug”
BackgroundSelf-citationNoguchi, A., Matsumura, S., Dezawa, M., Tada, M., Yanazawa, M., Ito, A., Akioka, M., Kikuchi, S., Sato, M., Ideno, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000208 · Cited by 173
Jan, A., Adolfsson, O., Allaman, I., Buccarello, A.-L., Magistretti, P. J., Pfeifer, A., Muhs, A., & Lashuel, H. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172411 · Cited by 173
Kovacs, G. G., Wagner, U., Dumont, B., Pikkarainen, M., Osman, A. A., Streichenberger, N., Leisser, I., Verchère, J., Baron, T., Alafuzoff, I., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0964-x · Cited by 169 · cited 1×
“b-sheet rich oligomers of this protein [74,151].”
Nývlt, J. (1995) · Crystal Research and Technology · doi:10.1002/crat.2170300402 · Cited by 168
Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers
Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167
Self-citationEmadi, S., Barkhordarian, H., Wang, M. S., Schulz, P., & Sierks, M. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.089 · Cited by 163
Arrigo, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.011 · Cited by 163
Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
Lopez del Amo, J. M., Fink, U., Dasari, M., Grelle, G., Wanker, E. E., Bieschke, J., & Reif, B. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.013 · Cited by 161 · cited 2×
“Subsequent NMR analysis determined that in this oligomer population, C-terminal b-sheet (residues 22–39) was included into the secondary structure formation, whereas the N-terminal half of the peptide was unstructured due to the EGCG binding [32].”
BackgroundKaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D.-P., & Fink, A. L. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.046 · Cited by 159
Wu, J. W., Breydo, L., Isas, J. M., Lee, J., Kuznetsov, Y. G., Langen, R., & Glabe, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069542 · Cited by 158 · cited 4×
“rils [28], and oligomer seeding has been shown for tau [121,123], a-synuclein [49,124], and ataxin [125].”
BackgroundInfluentialSelf-citationThe solution structure of human β2‐microglobulin reveals the prodromes of its amyloid transition
Verdone, G., Corazza, A., Viglino, P., Pettirossi, F., Giorgetti, S., Mangione, P., Andreola, A., Stoppini, M., Bellotti, V., & Esposito, G. (2002) · Protein Science · doi:10.1110/ps.29002 · Cited by 158
Ruggeri, F. S., Adamcik, J., Jeong, J. S., Lashuel, H. A., Mezzenga, R., & Dietler, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201409050 · Cited by 157
Kayed, R., Canto, I., Breydo, L., Rasool, S., Lukacsovich, T., Wu, J., Albay, R., Pensalfini, A., Yeung, S., Head, E., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-57 · Cited by 155
Self-citationSoluble and Mature Amyloid Fibrils in Drusen Deposits
Isas, J. M., Luibl, V., Johnson, L. V., Kayed, R., Wetzel, R., Glabe, C. G., Langen, R., & Chen, J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4207 · Cited by 153
Näsström, T., Fagerqvist, T., Barbu, M., Karlsson, M., Nikolajeff, F. K., Kasrayan, A., Ekberg, M., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.027 · Cited by 143 · cited 1×
“and less toxic than those formed in the presence of 4-oxo-2-nonenal [47].”
BackgroundBlack Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils
Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., & Bieschke, J. (2011) · Biochemistry · doi:10.1021/bi2012383 · Cited by 141
Plakoutsi, G., Bemporad, F., Calamai, M., Taddei, N., Dobson, C. M., & Chiti, F. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.043 · Cited by 139 · cited 1×
“tides, the conversion of amyloid oligomers from native-like to b-sheet rich forms has been shown to involve internal reorganization rather than dissociation and reassembly [99,112,113].”
BackgroundDopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
Lee, H.-J., Baek, S. M., Ho, D.-H., Suk, J.-E., Cho, E.-D., & Lee, S.-J. (2011) · Experimental and Molecular Medicine · doi:10.3858/emm.2011.43.4.026 · Cited by 137
Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
Lasagna-Reeves, C. A., Glabe, C. G., & Kayed, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236257 · Cited by 136
Eghiaian, F., Daubenfeld, T., Quenet, Y., van Audenhaege, M., Bouin, A., van der Rest, G., Grosclaude, J., & Rezaei, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607745104 · Cited by 136 · cited 1×
“where parts of C-terminal domain (residues 148–175) were unfolded and then refolded to b-structure [94,95].”
Effects of Various Flavonoids on the α -Synuclein Fibrillation Process
Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2010) · Parkinson s Disease · doi:10.4061/2010/650794 · Cited by 131
Self-citationKovacs, G. G., Breydo, L., Green, R., Kis, V., Puska, G., Lőrincz, P., Perju-Dumbrava, L., Giera, R., Pirker, W., Lutz, M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.020 · Cited by 129 · cited 1×
“b-sheet rich oligomers of this protein [74,151].”
Self-citationPasławski, W., Mysling, S., Thomsen, K., Jørgensen, T. J. D., & Otzen, D. E. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400491 · Cited by 126 · cited 2×
“to be not on the pathway to fibril formation, whereas the oligomers with larger protected core were easily converted to fibrils [41,44].”
BackgroundBae, E.-J., Ho, D.-H., Park, E., Jung, J. W., Cho, K., Hong, J. H., Lee, H.-J., Kim, K. P., & Lee, S.-J. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4429 · Cited by 125
Tryptophan Fluorescence Reveals Structural Features of α-Synuclein Oligomers
van Rooijen, B. D., van Leijenhorst-Groener, K. A., Claessens, M. M. A. E., & Subramaniam, V. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.021 · Cited by 123
Tay, W. M., Huang, D., Rosenberry, T. L., & Paravastu, A. K. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.003 · Cited by 121 · cited 2×
“In Ab42 oligomers formed in the presence of SDS, residues 25–40 were found to form b-strands that were arranged in the antiparallel fashion, whereas the structure of the N-terminal half of the peptide was unclear [14,18].”
BackgroundHatami, A., Albay, R., Monjazeb, S., Milton, S., & Glabe, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594846 · Cited by 120
The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide
Wei, L., Jiang, P., Xu, W., Li, H., Zhang, H., Yan, L., Chan‐Park, M. B. E., Liu, X., Tang, K., Mu, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166678 · Cited by 120 · cited 4×
“[128] Zhang, M., Hu, R., Chen, H., Chang, Y., Gong, X., Liu, F. and Zheng, J. (2015) Interfacial interaction and lateral association of cross-seeding assemblies between hIAPP and rIAPP oligomers.”
BackgroundInfluentialHerrera, F. E., Chesi, A., Paleologou, K. E., Schmid, A., Munoz, A., Vendruscolo, M., Gustincich, S., Lashuel, H. A., & Carloni, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003394 · Cited by 119
pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers
Tipping, K. W., Karamanos, T. K., Jakhria, T., Iadanza, M. G., Goodchild, S. C., Tůma, R., Ranson, N. A., Hewitt, E. W., & Radford, S. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423174112 · Cited by 118 · cited 1×
“4 resulted in the formation of oligomers that appear less structured than the fibrils or monomers [87].”
BackgroundGeneration and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
Hillen, H., Barghorn, S., Striebinger, A., Labkovsky, B., Müller, R., Nimmrich, V., Nolte, M. W., Perez-Cruz, C., van der Auwera, I., van Leuven, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5721-09.2010 · Cited by 113
Understanding the complex mechanisms of β2-microglobulin amyloid assembly
Eichner, T., & Radford, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08186.x · Cited by 112 · cited 1×
“microglobulin (b-2m) at neutral pH was shown to be dependent on the isomerization of His31-Pro32 bond from cis- to trans-conformation, leading to the partial unfolding of one of the b-strands and to a consequent expose of a highly aggregation-prone region of the protein [82].”
BackgroundCarulla, N., Zhou, M., Arimon, M., Gairí, M., Giralt, E., Robinson, C. V., & Dobson, C. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812227106 · Cited by 112 · cited 1×
“Early stage oligomers formed from intrinsically disordered proteins and peptides such as IAPP [97], PI3-SH3 domain [98], Ab [22–”
BackgroundChen, L., Yan, W., Wang, X., & He, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009052 · Cited by 111 · cited 1×
“Chemical modifications of a-synuclein, such as methionine oxidation [66,67], intramolecular crosslinking by transglutaminase [68,69], and formation of AGE adducts [70,71], also promoted formation of the disordered oligomers.”
BackgroundHorváth, I., Weise, C., Andersson, E. K., Chorell, E., Sellstedt, M., Bengtsson, C., Olofsson, A., Hultgren, S. J., Chapman, M. R., Wolf‐Watz, M., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209829m · Cited by 108 · cited 1×
“to be not on the pathway to fibril formation, whereas the oligomers with larger protected core were easily converted to fibrils [41,44].”
BackgroundThe structure of dopamine induced α-synuclein oligomers
Rekas, A., Knott, R. B., Sokolova, A. V., Barnham, K. J., Perez, K. A., Masters, C. L., Drew, S. C., Cappai, R., Curtain, C. C., & Pham, C. L. L. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0595-x · Cited by 106
A regulatable switch mediates self-association in an immunoglobulin fold
Calabrese, M. F., Eakin, C. M., Wang, J., & Miranker, A. D. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1483 · Cited by 101
Zhou, W., Long, C., Reaney, S. H., Di Monte, D. A., Fink, A. L., & Uversky, V. N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.004 · Cited by 100 · cited 2×
“Chemical modifications of a-synuclein, such as methionine oxidation [66,67], intramolecular crosslinking by transglutaminase [68,69], and formation of AGE adducts [70,71], also promoted formation of the disordered oligomers.”
BackgroundSelf-citationDetecting Morphologically Distinct Oligomeric Forms of α-Synuclein
Emadi, S., Kasturirangan, S., Wang, M. S., Schulz, P., & Sierks, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806559200 · Cited by 98
Braga, C. A. C. A., Follmer, C., Palhano, F. L., Khattar, E., de Freitas, M. S., Romão, L. F., Giovanni, S. D., Lashuel, H. A., Silva, J. L., & Foguel, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.027 · Cited by 97 · cited 1×
“selengiline [61], b-hairpins [62] and many other compounds [63,64] induced formation of mostly disordered a-synuclein oligomers, although in some cases [52] the residual b-structure was found.”
BackgroundStable, Metastable, and Kinetically Trapped Amyloid Aggregate Phases
Miti, T., Mulaj, M., Schmit, J. D., & Muschol, M. (2014) · Biomacromolecules · doi:10.1021/bm501521r · Cited by 94 · cited 1×
“required conformational changes in protein molecules, the oligomer formation process is much slower [105].”
BackgroundPasławski, W., Mysling, S., Thomsen, K., Jørgensen, T. J. D., & Otzen, D. E. (2014) · Angewandte Chemie · doi:10.1002/ange.201400491 · Cited by 93
Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J., & Sierks, M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/260787 · Cited by 90 · cited 1×
“For example, for small Ab [26] and tau [134] oligomers, cytotoxicity increased with oligomer size.”
BackgroundCapitini, C., Conti, S., Perni, M., Guidi, F., Cascella, R., De Poli, A., Penco, A., Relini, A., Cecchi, C., & Chiti, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086720 · Cited by 88 · cited 1×
“A number of stable, yet highly disordered oligomers have been observed as well [32,67,108].”
BackgroundSudnitsyna, M. V., Mymrikov, E. V., Seit‐Nebi, A. S., & Gusev, N. B. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312799277875 · Cited by 87 · cited 2×
“morphologies, with the size and structure of the oligomers dictated by the features of the N- and C-termini [177,178,180].”
BackgroundHuang, D., Zimmerman, M. I., Martin, P. K., Nix, A. J., Rosenberry, T. L., & Paravastu, A. K. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.04.004 · Cited by 86 · cited 1×
“In Ab42 oligomers formed in the presence of SDS, residues 25–40 were found to form b-strands that were arranged in the antiparallel fashion, whereas the structure of the N-terminal half of the peptide was unclear [14,18].”
BackgroundDetailed Biophysical Characterization of the Acid-Induced PrPc to PrPβ Conversion Process
Bjorndahl, T. C., Zhou, G., Liu, X., Pérez, R., Semenchenko, V., Saleem, F., Acharya, S., Bujold, A. R., Sobsey, C. A., & Wishart, D. S. (2010) · Biochemistry · doi:10.1021/bi101435c · Cited by 86 · cited 1×
“were b-sheet rich and had lower stability and lower extent of b-structure compared to fibrils [90,92,93].”
BackgroundStructural Investigations of Molecular Machines by Solid-State NMR
Loquet, A., Habenstein, B., & Lange, A. (2013) · Accounts of Chemical Research · doi:10.1021/ar300320p · Cited by 85
Liu, T., & Bitan, G. (2012) · ChemMedChem · doi:10.1002/cmdc.201100585 · Cited by 82
Fonarev, A. B., Shugaliĭ, A. V., Papina, R. I., & Todorov, I. N. (1985) · PubMed · Cited by 82
Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment
Morgado, I., Wieligmann, K., Bereza, M., Rönicke, R., Meinhardt, K., Annamalai, K., Baumann, M., Wacker, J., Hortschansky, P., Malešević, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206433109 · Cited by 80 · cited 1×
“KW1 is a bivalent antibody that specifically recognizes non-SDS stable Ab40 oligomers with diameter of 17 nm [152], presumably by binding to the motif formed by the residues 18–20 of the Ab peptide.”
BackgroundAmyloid β-Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03
Zheng, X., Liu, D., Klärner, F., Schrader, T. H., Bitan, G., & Bowers, M. T. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b00692 · Cited by 79 · cited 1×
“case of Ab, they have been shown to compact the structures of dimers and tetramers and prevented formation of more toxic higher-order oligomers [143].”
BackgroundSouillac, P. O., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi034652m · Cited by 79
Self-citationRole of Advanced Glycation on Aggregation and DNA Binding Properties of α-Synuclein
Padmaraju, V., Bhaskar, J. J., Prasada Rao, U. J. S., Salimath, P. V., & Rao, K. S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101965 · Cited by 78
Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis
Pountney, D. L., Voelcker, N. H., & Gai, W. (2005) · Neurotoxicity Research · doi:10.1007/bf03033776 · Cited by 76 · cited 1×
“013 In addition, Ab [29,30] and a-synuclein [115,116] oligomers can assemble into annular protofibrils, doughnut-shaped structures”
BackgroundThe structure of fibrils from ‘misfolded’ proteins
Meier, B. H., & Böckmann, A. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.12.001 · Cited by 75
Luth, E. S., Bartels, T., Dettmer, U., Kim, N. C., & Selkoe, D. J. (2015) · Biochemistry · doi:10.1021/bi501188a · Cited by 74
Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation
Feng, S., Song, X.-H., & Zeng, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.037 · Cited by 74 · cited 1×
“can also assemble into linear protofibrils with beads-on-a-string morphology [117,118].”
BackgroundHigh Stability and Cooperative Unfolding of α-Synuclein Oligomers
Pasławski, W., Andreasen, M., Nielsen, S. B., Lorenzen, N., Thomsen, K., Kaspersen, J. D., Pedersen, J. S., & Otzen, D. E. (2014) · Biochemistry · doi:10.1021/bi5007833 · Cited by 73
Kachooei, E., Moosavi‐Movahedi, A. A., Khodagholi, F., Ramshini, H., Shaerzadeh, F., & Sheibani, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041344 · Cited by 70 · cited 1×
“folded proteins such as insulin [100,101], SOD-1 [102], and acylphosphatase [103,104] largely preserved the native fold of”
BackgroundAmyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease
Guerrero-Muñoz, M. J., Castillo-Carranza, D. L., Krishnamurthy, S., Paulucci-Holthauzen, A. A., Sengupta, U., Lasagna-Reeves, C. A., Ahmad, Y., Jackson, G. R., & Kayed, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.008 · Cited by 67
α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles
Varkey, J., Mizuno, N., Hegde, B. G., Cheng, N., Steven, A. C., & Langen, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476697 · Cited by 67 · cited 1×
“Metastable a-helical oligomers of a-synuclein were observed upon incubation of this protein with lipid membranes [75] and iso-”
BackgroundKvam, E., Nannenga, B. L., Wang, M. S., Jia, Z., Sierks, M. R., & Messer, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005727 · Cited by 64
Diverse Metastable Structures Formed by Small Oligomers of α-Synuclein Probed by Force Spectroscopy
Neupane, K., Solanki, A., Sosova, I., Belov, M., & Woodside, M. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086495 · Cited by 63 · cited 1×
“Force spectroscopy [40] and other methods [39] showed that a-synuclein oligomer stabil-”
MethodStructural Insights into Amyloid Oligomers of the Parkinson Disease-related Protein α-Synuclein
Gallea, J. I., & Celej, M. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566695 · Cited by 63
Crystal Structure of a Human Prion Protein Fragment Reveals a Motif for Oligomer Formation
Apostol, M. I., Perry, K., & Surewicz, W. K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403001q · Cited by 62 · cited 5×
“A – globulomer, Ab42 [33]; B – hexamer, b2-microglobulin [85]; C – hexamer, PrP fragment [91]A; D – hexamer, aB-crystallin fragment [15].”
BackgroundInfluentialTissue transglutaminase modulates α‐synuclein oligomerization
Segers‐Nolten, I. M. J., Wilhelmus, M. M. M., Veldhuis, G., van Rooijen, B. D., Drukarch, B., & Subramaniam, V. (2008) · Protein Science · doi:10.1110/ps.036103.108 · Cited by 61
Ladiwala, A. R. A., Mora‐Pale, M., Lin, J. C., Bale, S. S., Fishman, Z. S., Dordick, J. S., & Tessier, P. M. (2011) · ChemBioChem · doi:10.1002/cbic.201100123 · Cited by 60 · cited 1×
“Partially disordered Ab oligomers formed in the presence of polyphenols were non-toxic [31,136,137], whereas more struc-”
BackgroundMysling, S., Betzer, C., Jensen, P. H., & Jørgensen, T. J. D. (2013) · Biochemistry · doi:10.1021/bi4009193 · Cited by 58 · cited 1×
“gation (AUC) measurements combined with the H/D exchange [41,42] and fluorescence analyses [43] have shown that amyloid core (residues 40–80) is consistently protected from the solvent in oligomers, and in some oligomer preparations this protection is extended on all N-terminal half of the protein (residues 1–90) [41].”
BackgroundMolecular Tweezers Inhibit Islet Amyloid Polypeptide Assembly and Toxicity by a New Mechanism
Lopes, D. H. J., Attar, A., Nair, G., Hayden, E. Y., Du, Z., McDaniel, K., Dutt, S., Bandmann, H., Bravo‐Rodriguez, K., Mittal, S., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00146 · Cited by 53
Attar, A., & Bitan, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990496 · Cited by 51
Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23
Murakami, K., Horikoshi-Sakuraba, Y., Murata, N., Noda, Y., Masuda, Y., Kinoshita, N., Hatsuta, H., Murayama, S., Shirasawa, T., Shimizu, T., et al. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100072e · Cited by 50
Dissecting the Mechanisms of Tissue Transglutaminase-induced Cross-linking of α-Synuclein
Schmid, A. W., Chiappe, D., Pignat, V., Grimminger, V., Hang, I., Moniatte, M., & Lashuel, H. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809067200 · Cited by 48 · cited 1×
“Chemical modifications of a-synuclein, such as methionine oxidation [66,67], intramolecular crosslinking by transglutaminase [68,69], and formation of AGE adducts [70,71], also promoted formation of the disordered oligomers.”
BackgroundNäsström, T., Wahlberg, T., Karlsson, M., Nikolajeff, F. K., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.005 · Cited by 48
Molecular Tweezers Targeting Transthyretin Amyloidosis
Ferreira, N., Pereira-Henriques, A., Attar, A., Klärner, F., Schrader, T. H., Bitan, G., Gales, L., Saraiva, M. J., & Almeida, M. R. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0256-8 · Cited by 48
A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
Lasagna‐Reeves, C. A., Rousseaux, M. W. C., Guerrero‐Munoz, M. J., Park, J., Jafar‐Nejad, P., Richman, R., Lü, N., Sengupta, U., Litvinchuk, A., Orr, H. T., et al. (2015) · eLife · doi:10.7554/elife.07558 · Cited by 46 · cited 1×
“rils [28], and oligomer seeding has been shown for tau [121,123], a-synuclein [49,124], and ataxin [125].”
BackgroundDefining the Native State of α-Synuclein
Selkoe, D., Dettmer, U., Luth, E., Kim, N., Newman, A., & Bartels, T. (2014) · Neurodegenerative Diseases · doi:10.1159/000355516 · Cited by 45
Ma, B., & Nussinov, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133488 · Cited by 42
Conformational Properties of β-PrP
Hosszu, L. L. P., Trevitt, C. R., Jones, S., Batchelor, M., Scott, D. J., Jackson, G. S., Collinge, J., Waltho, J. P., & Clarke, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809173200 · Cited by 41
Distinct higher-order α-synuclein oligomers induce intracellular aggregation
Illes‐Toth, E., Ramos, M. R., Cappai, R., Dalton, C., & Smith, D. P. (2015) · Biochemical Journal · doi:10.1042/bj20150159 · Cited by 37
Zhang, M., Hu, R., Chen, H., Chang, Y., Gong, X., Liu, F., & Zheng, J. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp05658b · Cited by 30 · cited 4×
“pletely sequence-specific, as cross-seeding was observed between oligomers of Ab and tau [123], Ab40 and Ab42 [126], TDP-43 and Ab [127], and human and rat IAPP [128].”
BackgroundInfluentialBreaking the Code of Amyloid-βOligomers
Lesné, S. E. (2013) · International Journal of Cell Biology · doi:10.1155/2013/950783 · Cited by 29
Isolation and characterization of antibody fragments selective for toxic oligomeric tau
Tian, H., Davidowitz, E. J., Lopez, P. L. D. C., He, P., Schulz, P., Moe, J. G., & Sierks, M. R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.002 · Cited by 28 · cited 1×
“such as tau [156] and TDP-43 [157] have been described as well.”
BackgroundBinding interactions of agents that alter α-synuclein aggregation
Sivanesam, K., Byrne, A., Bisaglia, M., Bubacco, L., & Andersen, N. H. (2015) · RSC Advances · doi:10.1039/c5ra00325c · Cited by 28
Zhou, W., Long, C., Reaney, S. H., Monte, D. A. D., Fink, A. L., & Uversky, V. N. (2013) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 26
Self-citationHerzog, G., Shmueli, M. D., Levy-Kanfo, L., Engel, L., Gazit, E., Klärner, F., Schrader, T. H., Bitan, G., & Segal, D. (2015) · Biochemistry · doi:10.1021/bi501092p · Cited by 25
Leney, A. C., Pashley, C. L., Scarff, C. A., Radford, S. E., & Ashcroft, A. E. (2013) · Molecular BioSystems · doi:10.1039/c3mb70420c · Cited by 23
Characterizing Antibody Specificity to Different Protein Morphologies by AFM
Wang, M. S., Zameer, A., Emadi, S., & Sierks, M. R. (2008) · Langmuir · doi:10.1021/la8025914 · Cited by 20
Venkataramani, V., Wirths, O., Budka, H., Härtig, W., Kovács, G. G., & Bayer, T. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111379 · Cited by 19 · cited 1×
“recognize only the oligomeric form of this peptide [150].”
BackgroundWilliams, S. M., Venkataraman, L., Tian, H., Khan, G., Harris, B. T., & Sierks, M. R. (2015) · Journal of Visualized Experiments · doi:10.3791/52584 · Cited by 17 · cited 6×
“such as tau [156] and TDP-43 [157] have been described as well.”
BackgroundInfluentialEarly oligomerization stages for the non-amyloid component of α-synuclein amyloid
Eugene, C., Laghaei, R., & Mousseau, N. (2014) · The Journal of Chemical Physics · doi:10.1063/1.4896381 · Cited by 16 · cited 1×
“a-synuclein), a-helical intermediates may also be involved [80,81,107].”
BackgroundFormation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis
Clos, A. L., Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Jackson, G. R., Kelly, B. C., Beachkofsky, T. M., & Kayed, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10508.x · Cited by 16
Nannenga, B. L., Zameer, A., & Sierks, M. R. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.014 · Cited by 15
From an Inactive Prokaryotic SOD Homologue to an Active Protein through Site-Directed Mutagenesis
Banci, L., Benvenuti, M., Bertini, I., Cabelli, D. E., Calderone, V., Fantoni, A., Mangani, S., Migliardi, M., & Viezzoli, M. S. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052790o · Cited by 12 · cited 2×
“folded proteins such as insulin [100,101], SOD-1 [102], and acylphosphatase [103,104] largely preserved the native fold of”
BackgroundDavis, P. J., Holmes, D. F., Waltho, J. P., & Staniforth, R. A. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.05.014 · Cited by 11
Molecular Mechanisms of Protein Misfolding
Breydo, L., & Uversky, V. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00001-8 · Cited by 11
Self-citationOverview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins
Rahimi, F., & Bitan, G. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_1 · Cited by 9 · cited 1×
“SDS–PAGE, reactivity of conformation-specific antibodies, DLS, various spectroscopic methods) are not always able to distinguish different oligomer populations and sometimes suffer from artefacts [12,13].”
BackgroundWilliams, S. M., Venkataraman, L., Tian, H., Khan, G., Harris, B. T., & Sierks, M. R. (2015) · Journal of Visualized Experiments · doi:10.3791/52584-v · Cited by 8
Preparation and Structural Characterization of Pre-fibrillar Assemblies of Amyloidogenic Proteins
Frydman‐Marom, A., Bram, Y., & Gazit, E. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_3 · Cited by 2
Cited by
In vivo aspects of protein folding and quality control
Balchin, D., Hayer-Hartl, M., & Hartl, F. U. (2016) · Science · doi:10.1126/science.aac4354 · Cited by 1,439
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing
Alberti, S., & Hyman, A. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00326-6 · Cited by 1,160
Beal, D. M., Tournus, M., Marchante, R., Purton, T. J., Smith, D. P., Tuite, M. F., Doumic, M., & Xue, W.-F. (2020) · iScience · doi:10.1016/j.isci.2020.101512 · Cited by 29
Metadata
- Authors
- Breydo, L., & Uversky, V. N.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2015-07-17
- Volume
- 589
- Issue
- 19PartA
- Pages
- 2640-2648
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W896868469
- Cited by
- 174
- References
- 178
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.